Skip to main content
. 2017 Apr 27;6(5):e1312240. doi: 10.1080/2162402X.2017.1312240

Figure 1.

Figure 1.

Evaluation of CD3, PD-L1 protein and their associations in nasopharyngeal carcinoma patients. Tumor and immune cell PD-L1 protein (A) and intratumoral and peritumoral CD3+ lymphocytes (B). Correlation between intratumoral (C) or peritumoral CD3+ lymphocytes and TCs-PD-L1 (D), and correlation between intratumoral (E) or peritumoral CD3+ lymphocytes (F) and ICs- PD-L1 expression.